JB Pharma Executive and Leadership Team

John Berryhour, the President & Chief Executive Officer at JB Pharma, directs the overarching corporate strategy and operational execution. Overseeing all business units, the President & Chief Executive Officer ensures alignment with the company's core values of simplicity, reliability, and agility. This leadership role involves driving market expansion and fostering innovation across the diverse portfolio of high-quality formulations. By optimizing resource allocation and setting strategic priorities, John Berryhour directly impacts the company's legacy of delivering healthcare excellence. Ultimately, Berryhour secures sustained growth and enhances patient access to effective treatments, reinforcing JB Pharma's commitment to ethical pharmaceutical practices.

Kaushal Solanki, the Chief Financial Officer at JB Pharma, manages all financial operations and fiscal strategy. Overseeing treasury, accounting, and financial planning, the Chief Financial Officer ensures robust financial health and compliance with ethical standards. This leadership position involves optimizing capital allocation, managing investment portfolios, and driving profitability across the company's diverse therapeutic areas. By implementing stringent financial controls and forecasting future market trends, Kaushal Solanki directly supports JB Pharma's mission of delivering reliable healthcare solutions. Ultimately, Solanki safeguards the company's financial integrity, enabling sustained investment in research and development and expanding access to essential treatments.

Kunal Khanna, the President, Operations, Mergers & Acquisitions at JB Pharma, spearheads the expansion and integration of business operations. Overseeing manufacturing, supply chain logistics, and strategic acquisitions, the President, Operations, Mergers & Acquisitions ensures operational efficiency and scalable growth. This critical role involves identifying and executing merger and acquisition opportunities that align with JB Pharma's strategic objectives and ethical foundation. By optimizing production processes and integrating new entities seamlessly, Kunal Khanna directly enhances the company's capacity to deliver high-quality formulations. Ultimately, Khanna drives operational excellence and market penetration, reinforcing JB Pharma's commitment to agility and reliability in healthcare delivery.

Milind Joshi, the Global President, Regulatory Management at JB Pharma, directs all global regulatory affairs and compliance initiatives. Overseeing adherence to international pharmaceutical standards and guidelines, the Global President, Regulatory Management ensures the integrity and accessibility of the company's product portfolio. This leadership function involves navigating complex regulatory landscapes across various markets, facilitating product approvals, and maintaining robust compliance frameworks. By ensuring all formulations meet stringent quality and safety requirements, Milind Joshi directly supports JB Pharma's legacy of delivering trusted healthcare solutions. Ultimately, Joshi upholds the company's commitment to ethics and reliability, enabling the expansion of effective treatments to patients worldwide.